This is part of a story dated, May 8, 2008
" Thoratec is redesigning its own next-generation device, called HeartMate III, to make it smaller, said Chief Executive Officer Gary Burbach in an interview. Burbach didn't say when it might be ready for human trials."
" Thoratec may supplement its pipeline by licensing or purchasing a new device, and rivals won't hurt Thoratec's revenue potential, he said."
All of it at:
http://www.bloomberg.com/apps/news?pid=newsarchive&sid=aImw1nInTWfA
VCR
ventracor limited
This is part of a story dated, May 8, 2008 " Thoratec is...
Add to My Watchlist
What is My Watchlist?